数据中心
龙虎榜
大单追踪
资金流向
业绩预告
新股申购
行情中心
沪深市场
香港市场
美国市场
全球市场
行业风云
全球市场
向上 向下

   SSKN
-- -- --

今开：-- 昨收：-- 最高：-- 最低：--
成交量：--万手 市盈率：-- 总市值($)：-- 换手率：--
加入自选股

首页概览 公司概况 财务分析 高管介绍 股本结构 公司新闻

股本结构

单位：万股
公告日期 2024-03-28 2023-11-14 2023-11-14 2023-09-25 2023-08-09 2023-05-15
证券总股本 3506.09 3504.88 3491.39 3491.39 3491.39 3488.15
普通股本 3506.09 3504.88 3491.39 3491.39 3491.39 3488.15
优先股 未披露 未披露 未披露 未披露 未披露 未披露
其他 未披露 未披露 未披露 未披露 未披露 未披露
变动日期 2023-12-31 2023-11-07 2023-09-30 2023-09-12 2023-08-07 2023-03-31
注释：中概股证券总股本=普通股股本/ 存托凭证比例

历史变动

公告日期 变动后普通股本（万股） 变动后优先股（万股） 变动原因 变动日期
2024-03-28 3506.09 未披露
更多>>
From December 31, 2022 to December 31, 2023 Issuance of restricted stock
2023-12-31
2023-11-14 3504.88 未披露 定期报告 2023-11-07
2023-11-14 3491.39 未披露
更多>>
From June 30, 2023 to September 30, 2023 Issuance of restricted stock
2023-09-30
2023-09-25 3491.39 未披露 定期报告 2023-09-12
2023-08-09 3491.39 未披露 定期报告 2023-08-07
2023-05-15 3488.15 未披露
更多>>
From January 1, 2023 to March 31, 2023 Issuance of restricted stock
2023-03-31
2023-03-31 3488.15 未披露 定期报告 2023-03-15
2022-08-10 3472.30 未披露
更多>>
From March 31, 2022 to June 30, 2022 Issuance of restricted stock
2022-06-30
2022-05-18 3472.31 未披露 定期报告 2022-04-25
2022-05-11 3472.30 未披露
更多>>
From January 1, 2022 to March 31, 2022 Issuance of common stock for acquisition
2022-03-31
2022-03-21 3472.30 未披露 定期报告 2022-03-18
2021-10-12 3436.47 未披露 定期报告 2021-10-06
2021-11-12 3436.47 未披露
更多>>
From June 30, 2021 to September 30, 2021 Exercise of stock options Issuance of restricted stock
2021-09-30
2021-08-13 3401.76 未披露 定期报告 2021-08-07
2021-08-16 3388.92 未披露
更多>>
From March 31, 2021 to June 30, 2021 Issuance of restricted stock
2021-06-30
2021-06-02 3380.10 未披露 定期报告 2021-05-10
2021-05-13 3388.92 未披露 定期报告 2021-05-07
2021-05-13 3381.73 未披露
更多>>
From January 1, 2021 To March 31, 2021 Issuance of restricted stock
2021-03-31
2021-03-25 3380.10 未披露
更多>>
from December 31, 2019 to December 31, 2020 Conversion of grantable preferred stock into common stock Exercise of stock options Issuance of restricted stock
2020-12-31
2020-11-10 3376.99 未披露 定期报告 2020-11-06
2020-11-27 3377.00 未披露 定期报告 2020-11-02
2020-11-10 3375.49 未披露 定期报告 2020-09-30
2020-08-12 3375.49 0.21
更多>>
From March 31, 2020 to June 30, 2020 Issuance of restricted stock
2020-06-30
2020-05-13 3371.44 0.21
更多>>
From January 1, 2020 to March 31, 2020 Conversion of convertible preferred stock into common stock
2020-03-31
2020-03-17 3371.44 未披露 定期报告 2020-03-10
2020-03-17 3293.23 0.21
更多>>
from December 31, 2018 to December 31, 2019 Conversion of convertible preferred stock into common stock Exercise of options Issuance of restricted stock
2019-12-31
2019-11-14 3290.33 0.21
更多>>
from March 31, 2019 to June 30, 2019 Conversion of convertible preferred stock into common stock Exercise of stock options
2019-06-30
2019-11-08 3112.06 0.69
更多>>
from January 1, 2019 to March 31, 2019 Conversion of convertible preferred stock into common stock Exercise of options
2019-03-31
2018-11-14 2994.31 1.00
更多>>
from JANUARY 1, 2018 to SEPTEMBER 30, 2018 Conversion of convertible preferred stock into common stock Sale of common stock, net of expenses of $2,336
2018-09-30
2018-09-18 2994.31 未披露 定期报告 2018-09-10
2018-08-14 2988.85 未披露 定期报告 2018-08-10
2018-08-14 2973.55 1.01
更多>>
from JANUARY 1, 2018 to JUNE 30, 2018 Conversion of convertible preferred stock into common stock Sale of common stock, net of expenses of $2,336 Common stock issuable
2018-06-30
2018-07-23 2849.31 未披露 定期报告 2018-06-12
2018-05-15 705.86 未披露 定期报告 2018-05-11
2018-04-27 473.48 未披露 定期报告 2018-04-13
2018-05-15 437.94 3.60
更多>>
From January 1, 2018 to March 31, 2018 Conversion of convertible preferred stock into common stock
2018-03-31
2018-04-02 437.94 未披露 定期报告 2018-03-22
2018-04-02 430.44 3.62
更多>>
from December 31, 2016 to December 31, 2017 Conversion of convertible preferred stock into common stock Issuance of convertible preferred stock in exchange for convertible debentures Conversion of senior secured convertible debentures into common stock Issuance of common stock for fractional shares in reverse stock split
2017-12-31
2017-11-14 407.61 未披露
更多>>
During October 2017, investors converted Series C Preferred Stock amounting to $4,299 into 1,598,346 shares of common stock.
2017-11-10
2017-11-14 247.77 4.34
更多>>
From JANUARY 1, 2017 to SEPTEMBER 30, 2017 Conversion of convertible preferred stock Conversion of senior secured convertible debentures Issuance of common stock for fractional shares in reverse stock split
2017-09-30
2017-08-11 247.77 0.29
更多>>
From JANUARY 1, 2017 to JUNE 30, 2017 Conversion of senior secured convertible debentures Conversion of convertible preferred stock Issuance of common stock for fractional shares in reverse stock split
2017-06-30
2017-05-15 242.77 未披露 定期报告 2017-05-12
2017-05-15 218.19 0.60
更多>>
From JANUARY 1, 2017 to April 7, 2017 Conversion of senior secured convertible debentures On April 6, 2017, STRATA Skin Sciences, Inc. announced a 1-for-5 reverse stock split of the Company's common stock. The 1-for-5 reverse stock split will be effective at 5:00 p.m., Eastern Time, on Thursday, April 6, 2017, and the Company's common stock will trade on the NASDAQ Capital Market on a post-split basis at the open of trading on Friday, April 7, 2017.
2017-04-07
2017-03-13 1090.95 未披露 定期报告 2017-03-09
2017-02-17 1088.45 未披露 定期报告 2017-02-07
2017-03-13 1083.45 0.60
更多>>
From December 31, 2015 to December 31, 2016 Conversion of convertible preferred stock Conversion of senior secured convertible debentures
2016-12-31
2016-11-14 1075.78 未披露 定期报告 2016-11-14
2016-11-14 1073.28 0.62
更多>>
From January 1, 2016 to September 30, 2016 Conversion of senior secured convertible debentures Conversion of preferred stock
2016-09-30
2016-09-16 1073.28 未披露 定期报告 2016-08-31
2016-08-12 1065.28 未披露 定期报告 2016-08-11
2016-08-12 1061.28 0.65
更多>>
from January 1, 2016 to June 30, 2016 Conversion of senior secured convertible debentures
2016-06-30
2016-05-16 1058.78 未披露 定期报告 2016-05-13
2016-05-16 1050.34 0.65
更多>>
from January 1, 2016 to March 31, 2016 Conversion of senior secured convertible debentures
2016-03-31
2016-03-15 1050.34 未披露 定期报告 2016-03-11
2016-03-15 1028.34 0.65
更多>>
From December 31, 2014 to December 31, 2015 Conversion of convertible preferred stock Stock-based compensation Conversion of senior secured convertible debentures
2015-12-31
2015-11-16 1018.34 未披露
更多>>
During October 2015, investors converted debentures amounting to $676 into 296,035 shares of common stock.
2015-11-13
2015-11-16 988.74 0.65
更多>>
from January 1, 2015 to September 30, 2015 Conversion of convertible preferred stock Conversion of senior secured convertible debentures
2015-09-30
2015-08-14 988.74 未披露 定期报告 2015-08-13
2015-08-14 899.67 0.65
更多>>
from January 1, 2015 to June 30, 2015 Conversion of convertible preferred stock Conversion of senior secured convertible debentures
2015-06-30
2015-05-14 811.31 未披露 定期报告 2015-04-30
2015-05-14 752.51 1.03 定期报告 2015-03-31
2015-03-30 752.51 未披露
更多>>
On February 5, 2014, pursuant to a securities purchase agreement dated as of January 31, 2014, we sold to the Purchasers (i) an aggregate of 12,300 shares of Series A Preferred Stock, par value $0.10 and a stated value of $1,000 per share, convertible into 1,464,287 shares of common stock at an initial conversion price of $8.40, and (ii) warrants to purchase up to 1,329,731 shares of common stock for net proceeds of approximately $11.5 million.
2015-03-30
2015-03-30 603.72 1.18
更多>>
from December 31, 2013 to December 31, 2014 Issuance of Series A convertible preferred stock and common stock in connection with the February 2014 private placement (net of issuance costs of $992) Redemption of Series A convertible preferred stock in connection with the July 2014 private placement Issuance of Series B convertible preferred stock in connection with the July 2014 private placement Conversion of 0.5 shares of Series B convertible preferred stock Conversion of $1,589 in convertible debentures Exercise of prefunded warrants Share-based compensation expense On July 9, 2014, the Company effected a previously authorized 1-for-10 reverse stock split of its common stock. The reverse split took effect at the start of trading on July 10, 2014 on a 1-for-10 split basis. All prior periods have been retroactively adjusted to reflect the reverse stock split
2014-12-31
2014-11-14 603.72 未披露 定期报告 2014-10-31
2014-11-14 521.77 1.23 定期报告 2014-09-30
2014-08-19 521.40 未披露 定期报告 2014-08-15
2014-08-14 521.49 未披露 定期报告 2014-07-31
2014-08-14 521.40 1.23
更多>>
On July 9, 2014, the Company effected a previously authorized 1-for-10 reverse stock split of its common stock. The reverse split took effect at the start of trading on July 10, 2014 on a 1-for-10 split basis. All prior periods have been retroactively adjusted to reflect the reverse stock split
2014-07-11
2014-05-13 5210.75 1.23 定期报告 2014-03-31
2014-04-14 5210.75 未披露 定期报告 2014-03-28
2014-03-18 5210.10 未披露 定期报告 2014-03-14
2014-03-17 4775.58 未披露 定期报告 2014-02-28
2014-03-17 4750.16 未披露
更多>>
from December 31, 2012 to December 31, 2013 Issuance of shares of common stock in connection with Public Offering (net of issuance costs of $1,025) Issuance of shares of common stock and warrants in connection with 2013 Direct Placement (net of issuance costs of $3,426) Exercise of options Share-based compensation expense
2013-12-31
2013-11-08 4737.29 未披露 定期报告 2013-10-31
2013-11-06 4313.90 未披露 定期报告 2013-09-30
2013-08-07 4311.21 未披露 定期报告 2013-06-30
2013-03-05 4303.71 未披露 定期报告 2013-02-28
2013-03-05 3220.47 未披露
更多>>
from December 31, 2011 to December 31, 2012 Cashless exercise of options Exercise of options Issuance of shares of common stock in connection with an ATM public offering (net of expenses)
2012-12-31
2012-11-07 3160.41 未披露 定期报告 2012-10-31
2012-11-07 3132.39 未披露 定期报告 2012-09-30
2012-08-07 3051.93 未披露 定期报告 2012-07-31
2012-05-03 3033.22 未披露 定期报告 2012-03-31
2012-03-09 3030.72 未披露 定期报告 2012-02-29
2012-03-09 3030.75 未披露
更多>>
from December 31, 2010 to December 31, 2011 Exercise of options Issuance of shares of common stock in connection with a public offering (net of expenses) Issuance of common stock award
2011-12-31
2011-03-03 2526.25 未披露
更多>>
from dec 31 2009 to dec 31 2010 Cashless exercise of options Exercise of warrants Cashless exercise of warrants Issuance of shares of common stock in connection with a public offering(net of expenses) Issuance of shares of common stock in connection with a Committed Equity Financing Facility (CEFF) (net of expenses) Share-based compensation expense
2010-12-31
2010-11-05 2525.31 未披露 定期报告 2010-11-01
2010-08-06 2303.05 未披露 定期报告 2010-06-30
2010-05-10 2302.60 未披露 定期报告 2010-03-31
2010-03-04 2300.08 未披露 定期报告 2010-02-27
2010-03-04 2235.43 未披露
更多>>
from December 31, 2008 to December 31, 2009 Exercise of options Exercise of warrants Issuance of shares of common stock in connection with a public offering(net of expenses) Issuance of shares of common stock in connection with a Committed Equity Financing Facility (CEFF) (net of expenses)
2009-12-31
2009-03-02 1763.45 未披露
更多>>
from December 31, 2007 to December 31, 2008 Exercise of options Exercise of warrants Issuance of shares of common stock in connection with a public offering(net of expenses)
2008-12-31
2008-03-12 1540.19 未披露
更多>>
from December 31, 2006 to December 31, 2007 Exercise of Options Issuance of shares of common stock and warrants in connection with private placement (net of expenses)
2007-12-31
2007-03-15 1337.25 未披露 定期报告 2007-02-28
2007-03-15 1329.64 未披露
更多>>
from December 31, 2005 to December 31, 2006 Exercise of options Exercise of warrants Issuance of shares of common stock and warrants in connection with private placement (net of expenses)
2006-12-31
2006-03-29 1086.59 未披露 定期报告 2006-02-28
2006-03-29 1083.78 未披露
更多>>
from December 31, 2004 to December 31, 2005 Conversion of preferred stock in connection with the Initial Public Offering Exercise of option by non-employee directors Exercise of options by former employees Restricted stock award to employee Warrants exchanged for common stock Issuance of shares of common stock in connection with the Initial Public Offering (net of expenses)
2005-12-31
From December 31, 2022 to December 31, 2023 Issuance of restricted stock
From June 30, 2023 to September 30, 2023 Issuance of restricted stock
From January 1, 2023 to March 31, 2023 Issuance of restricted stock
From March 31, 2022 to June 30, 2022 Issuance of restricted stock
From January 1, 2022 to March 31, 2022 Issuance of common stock for acquisition
From June 30, 2021 to September 30, 2021 Exercise of stock options Issuance of restricted stock
From March 31, 2021 to June 30, 2021 Issuance of restricted stock
From January 1, 2021 To March 31, 2021 Issuance of restricted stock
from December 31, 2019 to December 31, 2020 Conversion of grantable preferred stock into common stock Exercise of stock options Issuance of restricted stock
From March 31, 2020 to June 30, 2020 Issuance of restricted stock
From January 1, 2020 to March 31, 2020 Conversion of convertible preferred stock into common stock
from December 31, 2018 to December 31, 2019 Conversion of convertible preferred stock into common stock Exercise of options Issuance of restricted stock
from March 31, 2019 to June 30, 2019 Conversion of convertible preferred stock into common stock Exercise of stock options
from January 1, 2019 to March 31, 2019 Conversion of convertible preferred stock into common stock Exercise of options
from JANUARY 1, 2018 to SEPTEMBER 30, 2018 Conversion of convertible preferred stock into common stock Sale of common stock, net of expenses of $2,336
from JANUARY 1, 2018 to JUNE 30, 2018 Conversion of convertible preferred stock into common stock Sale of common stock, net of expenses of $2,336 Common stock issuable
From January 1, 2018 to March 31, 2018 Conversion of convertible preferred stock into common stock
from December 31, 2016 to December 31, 2017 Conversion of convertible preferred stock into common stock Issuance of convertible preferred stock in exchange for convertible debentures Conversion of senior secured convertible debentures into common stock Issuance of common stock for fractional shares in reverse stock split
During October 2017, investors converted Series C Preferred Stock amounting to $4,299 into 1,598,346 shares of common stock.
From JANUARY 1, 2017 to SEPTEMBER 30, 2017 Conversion of convertible preferred stock Conversion of senior secured convertible debentures Issuance of common stock for fractional shares in reverse stock split
From JANUARY 1, 2017 to JUNE 30, 2017 Conversion of senior secured convertible debentures Conversion of convertible preferred stock Issuance of common stock for fractional shares in reverse stock split
From JANUARY 1, 2017 to April 7, 2017 Conversion of senior secured convertible debentures On April 6, 2017, STRATA Skin Sciences, Inc. announced a 1-for-5 reverse stock split of the Company's common stock. The 1-for-5 reverse stock split will be effective at 5:00 p.m., Eastern Time, on Thursday, April 6, 2017, and the Company's common stock will trade on the NASDAQ Capital Market on a post-split basis at the open of trading on Friday, April 7, 2017.
From December 31, 2015 to December 31, 2016 Conversion of convertible preferred stock Conversion of senior secured convertible debentures
From January 1, 2016 to September 30, 2016 Conversion of senior secured convertible debentures Conversion of preferred stock
from January 1, 2016 to June 30, 2016 Conversion of senior secured convertible debentures
from January 1, 2016 to March 31, 2016 Conversion of senior secured convertible debentures
From December 31, 2014 to December 31, 2015 Conversion of convertible preferred stock Stock-based compensation Conversion of senior secured convertible debentures
During October 2015, investors converted debentures amounting to $676 into 296,035 shares of common stock.
from January 1, 2015 to September 30, 2015 Conversion of convertible preferred stock Conversion of senior secured convertible debentures
from January 1, 2015 to June 30, 2015 Conversion of convertible preferred stock Conversion of senior secured convertible debentures
On February 5, 2014, pursuant to a securities purchase agreement dated as of January 31, 2014, we sold to the Purchasers (i) an aggregate of 12,300 shares of Series A Preferred Stock, par value $0.10 and a stated value of $1,000 per share, convertible into 1,464,287 shares of common stock at an initial conversion price of $8.40, and (ii) warrants to purchase up to 1,329,731 shares of common stock for net proceeds of approximately $11.5 million.
from December 31, 2013 to December 31, 2014 Issuance of Series A convertible preferred stock and common stock in connection with the February 2014 private placement (net of issuance costs of $992) Redemption of Series A convertible preferred stock in connection with the July 2014 private placement Issuance of Series B convertible preferred stock in connection with the July 2014 private placement Conversion of 0.5 shares of Series B convertible preferred stock Conversion of $1,589 in convertible debentures Exercise of prefunded warrants Share-based compensation expense On July 9, 2014, the Company effected a previously authorized 1-for-10 reverse stock split of its common stock. The reverse split took effect at the start of trading on July 10, 2014 on a 1-for-10 split basis. All prior periods have been retroactively adjusted to reflect the reverse stock split
On July 9, 2014, the Company effected a previously authorized 1-for-10 reverse stock split of its common stock. The reverse split took effect at the start of trading on July 10, 2014 on a 1-for-10 split basis. All prior periods have been retroactively adjusted to reflect the reverse stock split
from December 31, 2012 to December 31, 2013 Issuance of shares of common stock in connection with Public Offering (net of issuance costs of $1,025) Issuance of shares of common stock and warrants in connection with 2013 Direct Placement (net of issuance costs of $3,426) Exercise of options Share-based compensation expense
from December 31, 2011 to December 31, 2012 Cashless exercise of options Exercise of options Issuance of shares of common stock in connection with an ATM public offering (net of expenses)
from December 31, 2010 to December 31, 2011 Exercise of options Issuance of shares of common stock in connection with a public offering (net of expenses) Issuance of common stock award
from dec 31 2009 to dec 31 2010 Cashless exercise of options Exercise of warrants Cashless exercise of warrants Issuance of shares of common stock in connection with a public offering(net of expenses) Issuance of shares of common stock in connection with a Committed Equity Financing Facility (CEFF) (net of expenses) Share-based compensation expense
from December 31, 2008 to December 31, 2009 Exercise of options Exercise of warrants Issuance of shares of common stock in connection with a public offering(net of expenses) Issuance of shares of common stock in connection with a Committed Equity Financing Facility (CEFF) (net of expenses)
from December 31, 2007 to December 31, 2008 Exercise of options Exercise of warrants Issuance of shares of common stock in connection with a public offering(net of expenses)
from December 31, 2006 to December 31, 2007 Exercise of Options Issuance of shares of common stock and warrants in connection with private placement (net of expenses)
from December 31, 2005 to December 31, 2006 Exercise of options Exercise of warrants Issuance of shares of common stock and warrants in connection with private placement (net of expenses)
from December 31, 2004 to December 31, 2005 Conversion of preferred stock in connection with the Initial Public Offering Exercise of option by non-employee directors Exercise of options by former employees Restricted stock award to employee Warrants exchanged for common stock Issuance of shares of common stock in connection with the Initial Public Offering (net of expenses)